| Daisy Roxanne Trujillo, LPN | |
|
208 Guachpangue Rd, Espanola, NM 87532-3424 | |
| (505) 747-8187 | |
| (505) 747-8306 |
| Full Name | Daisy Roxanne Trujillo |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 208 Guachpangue Rd, Espanola, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760732275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | L19499 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daisy Roxanne Trujillo, LPN 208 Guachpangue Rd, Espanola, NM 87532-3424 Ph: (505) 747-8187 | Daisy Roxanne Trujillo, LPN 208 Guachpangue Rd, Espanola, NM 87532-3424 Ph: (505) 747-8187 |
News Archive
Treatment with hyperbaric oxygen therapy can lead to significant neurologic improvements for stroke patients, show study results.
The International Herald Tribune's "Express Tribune" reports on a two-day HIV/AIDS awareness workshop held in Pakistan this week. Speaking on Monday at the inaugural session of the event, titled "The State of HIV in Pakistan-2011," Amir Maqbool, acting program manager of the National AIDS Control Program (NACP), stated that HIV/AIDS could not be controlled in the country without legislation and strong financial funding for prevention and control efforts, according to the newspaper.
New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.
Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing addiction treatments, announced today that a scientific abstract based on results of the Company's Phase II clinical trial of its opioid antagonist nasal spray treatment for patients with Binge Eating Disorder has been accepted for presentation at the American Psychiatric Association Annual Meeting taking place in San Francisco, California, May 18-22, 2013.
› Verified 1 days ago
Nenad Dobra, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1227 N Railroad Ave Ste C, Espanola, NM 87532 Phone: 505-747-8187 | |
Jeremy Martinez, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 208 Guachupangue Rd, Espanola, NM 87532 Phone: 505-852-3865 | |
Soraida Sanchez, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1227 N Railroad Ave Ste C, Espanola, NM 87532 Phone: 505-747-8187 | |
Aliyah Romero, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1227 N Railroad Ave Ste C, Espanola, NM 87532 Phone: 505-747-8187 | |
Gary Kniffin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 208 Guachpangue Rd, Espanola, NM 87532 Phone: 505-747-8187 |